beta-thujaplicin has been researched along with Carcinoma, Hepatocellular in 1 studies
beta-thujaplicin: structure
beta-thujaplicin : A monoterpenoid that is cyclohepta-2,4,6-trien-1-one substituted by a hydroxy group at position 2 and an isopropyl group at position 4. Isolated from Thuja plicata and Chamaecyparis obtusa, it exhibits antimicrobial activities.
Carcinoma, Hepatocellular: A primary malignant neoplasm of epithelial liver cells. It ranges from a well-differentiated tumor with EPITHELIAL CELLS indistinguishable from normal HEPATOCYTES to a poorly differentiated neoplasm. The cells may be uniform or markedly pleomorphic, or form GIANT CELLS. Several classification schemes have been suggested.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Zhang, G | 1 |
He, J | 1 |
Ye, X | 1 |
Zhu, J | 1 |
Hu, X | 1 |
Shen, M | 1 |
Ma, Y | 1 |
Mao, Z | 1 |
Song, H | 1 |
Chen, F | 1 |
1 other study available for beta-thujaplicin and Carcinoma, Hepatocellular
Article | Year |
---|---|
β-Thujaplicin induces autophagic cell death, apoptosis, and cell cycle arrest through ROS-mediated Akt and p38/ERK MAPK signaling in human hepatocellular carcinoma.
Topics: Aged; Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Autophagic Cell Death; Autophagosomes; | 2019 |